Microbiology-Immunology News

Targeted Immune Intervention and Stopping ART in Model of SIV Infection Leads to Control of Viral Replication and Reservoirs (09/12/2024)

CD8+ T Cells Increasingly Crucial in Pursuit of a Cure for HIV (06/25/2024)

Modulating Type 1 Interferon May Expand Treatment Options for COVID-19 (07/28/2023)

Emory Receives $28.5 Million NIH Grant for "Innovative HIV/AIDS Vaccine and Cure Research" (06/09/2022)

Emory Researchers Closer to Understanding Mechanisms that Support HIV Persistence (06/09/2022)

A Cure for HIV: Emory Receives $23.8 Million NIH Grant to Accelerate Research (09/07/2021)

New COVID-19 Vaccine Candidate Provides Effective Option for Low- to Mid-Income Countries (07/15/2021)

Yerkes Researchers Develop Low-Cost, Low-Dose RBD Trimer Protein-Based COVID-19 Vaccine Candidate (07/01/2021)

New Combination Immunotherapy Plus ART Expand Innate Cells Critical to Controlling HIV (05/17/2021)

Emory MVA COVID-19 Vaccine Safe and Effective in Animal Models (02/04/2021)

Inflammation-Blocking Medication Effectively Reduces COVID-19 Lung Inflammation (12/10/2020)

Yerkes Genomics Research Will Help Predict COVID-19 Disease Severity, Inform Treatment Decisions (08/06/2020)

Emory Researchers Show New Adjuvant Successful in Extending Immunity Against HIV (06/19/2020)

Yerkes Researchers Find Zika Infection Soon After Birth Leads to Long-Term Brain and Behavior Problems (05/22/2020)

Yerkes Awarded NIAID Grant to Develop COVID-19 Vaccine (05/18/2020)

New HIV Vaccine Combination Strategy Provides Better and More Durable Protection (05/11/2020)

Immunotherapy Combo Achieves Reservoir Shrinkage in HIV Model (03/17/2020)

In animal models, a 'shocking' step toward a potential HIV cure (01/22/2020)